Intas Pharmaceuticals Limited Vincristine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Vincristine Export Records India — #6 Exporter, 7 Shipments, $94.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vincristine

India Pharmaceutical Trade Intelligence

$2.0M253 Suppliers113 CountriesHS 30049043

ExportsIndia → ALGERIA13.3%India → COLOMBIA11.9%

ImportsGERMANY → India$1.1K UNITED STATES → India$50

#1 Supplier: VENUS REMEDIES #1 Buyer: ALPHARMA S.A.S

Intas Pharmaceuticals Limited — Vincristine Exporter #6 | $94.3K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Vincristine Exporter Profile

Indian Pharmaceutical Exporter · #6 for Vincristine · $94.3K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #6 Indian exporter of Vincristine with $94.3K in export value and 7 verified shipments. Intas Pharmaceuticals Limited holds a 4.6% market share in Vincristine exports across 2 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Vincristine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Vincristine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Vincristine?

Country	Value	Shipments	Share
ALGERIA	$270.2K	14	19.0%
COLOMBIA	$241.0K	17	16.9%
VENEZUELA	$113.9K	15	8.0%
SAUDI ARABIA	$98.7K	70

Who Are the Top Buyers of Vincristine from India?

Buyer	Country	Value	Orders
ALPHARMA S.A.S.	COLOMBIA	$127.9K	10
PHARMACIE CENTRALE DES HOPITAUX (PC	ALGERIA	$122.6K	8
SALEHIYA TRADING COMPANY	SAUDI ARABIA	$73.3K	36
PHARMACIE CENTRALE DE TUNISIE	TUNISIA	$59.5K	5
A S A S	COLOMBIA	$58.3K	3
ACCORD HEALTHCARE C/O QESTMED	SOUTH AFRICA	$29.4K	2
PHARMACEUTICAL DISTOLOZA S.A.	PERU	$26.8K	3
PRO DISTRIBUTORS / DPR PHARMACEUTIC	SOUTH AFRICA	$26.0K	2
A.S.A.S	COLOMBIA	$25.6K	3
HELIOS PHARMACEUTICAL COMPANY LIMIT	VIETNAM	$24.8K	3

India's Vincristine is purchased by 477 buyers worldwide. The top buyer is ALPHARMA S.A.S. (COLOMBIA), followed by PHARMACIE CENTRALE DES HOPITAUX (PC and SALEHIYA TRADING COMPANY.

How Does Intas Pharmaceuticals Limited Compare to Nearest Vincristine Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	UNITED BIOTECH PRIVATE LIMITED	$95.4K	32	12	$3.0K
5	NV REMEDIES PRIVATE LIMITED	$94.6K	7	3	$13.5K
6	INTAS PHARMACEUTICALS LIMITED ★	$94.3K	7	2	$13.5K
7	NEON LABORATORIES LIMITED	$75.0K	19	4	$3.9K
8	SWASTHYA HEALTHCARE PRIVATE LIMITED	$55.9K	13	2	$4.3K

Intas Pharmaceuticals Limited ranks #6 among 253 Indian Vincristine exporters. Average shipment value of $13.5K compared to the market average of $5.9K. The closest competitors by value are UNITED BIOTECH PRIVATE LIMITED and NV REMEDIES PRIVATE LIMITED.

Which Indian Ports Ship Vincristine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	333	25.4%
SAHAR AIR	317	24.2%
DELHI AIR CARGO ACC (INDEL4)	144	11.0%
DELHI AIR	128	9.8%
Bombay Air	82	6.3%
Delhi Air	35	2.7%
Bombay Air Cargo	32	2.4%
AHEMDABAD AIR ACC (INAMD4)	27	2.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Vincristine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vincristine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 477+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vincristine

Vincristine

Intas Pharmaceuticals Limited — Vincristine Exporter Profile

Intas Pharmaceuticals Limited — Vincristine Export Profile: Buyers & Destinations

Where Does India Export Vincristine?

Who Are the Top Buyers of Vincristine from India?

What Is India's Total Vincristine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Vincristine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Vincristine Exporters?

How Does Intas Pharmaceuticals Limited Compare to Nearest Vincristine Exporters?

Which Indian Ports Ship Vincristine Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Vincristine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vincristine Export Data from Intas Pharmaceuticals Limited

Vincristine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source